<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_TAS_Taipei_Entrepreneurship skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:TAS Taipei/Entrepreneurship</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Entrepreneurship - TAS Taipei iGEM Wiki</TITLE></P><DIV class="container" style="z-index:10;position:relative;"><DIV class="row center-block" style="text-align: left;"><NAV style="font-family:Lato;font-size:22px;background-color:#1C77C3;-webkit-transform: translateZ(0);z-index: 100;position: fixed;box-shadow: 0px 0px 10px black;"><UL style="margin-left:0px"><LI class="dropdown"><A href="https://2016.igem.org/Team:TAS_Taipei/Background"><H4 class="dropdown-toggle disabled" data-toggle="dropdown"><B>PROJECT</B></H4></A><DIV class="dropdown-menu"><DIV class="subcategories_container"><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Background">Background</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Achievements">Achievements</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Collaborations">Collaborations</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Parts">Parts</A></H5></DIV></DIV><DIV style="height:140px;"><H4><B>Cataracts</B> - the leading cause of blindness. Find out how we can non-invasively <B>treat</B> and <B>prevent</B> cataract formation.</H4></DIV></DIV></LI><LI class="dropdown"><A href="https://2016.igem.org/Team:TAS_Taipei/Experimental_Summary"><H4 class="dropdown-toggle disabled" data-toggle="dropdown"><B>EXPERIMENTAL</B></H4></A><DIV class="dropdown-menu"><DIV class="subcategories_container"><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Experimental_Summary#lensmodel">Lens Cataract Model</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Experimental_Summary#construct">Prevention and Treatment Constructs </A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Experimental_Summary#prototype">Delivery Prototype</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Notebook">Notebook</A></H5></DIV></DIV><DIV style="height:140px;"><H4>We build <B>constructs</B> to make our great ideas become reality. Follow along our discovery of exciting science!</H4></DIV></DIV></LI><LI class="dropdown"><A href="https://2016.igem.org/Team:TAS_Taipei/Model"><H4 class="dropdown-toggle disabled" data-toggle="dropdown"><B>MODEL</B></H4></A><DIV class="dropdown-menu"><DIV class="subcategories_container"><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Model#GSRFunc">GSR Function</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Model#prototype">Prototype Delivery</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Model#treatment">CH25H Treatment</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Model#software">Calculator</A></H5></DIV></DIV><DIV style="height:140px;"><H4><B>Computational Biology</B> provides us models that we cannot easily test experimentally. Click to find out the results of our modeling, and the math behind it!</H4></DIV></DIV></LI><LI class="dropdown"><A href="https://2016.igem.org/Team:TAS_Taipei/Human_Practices"><H4 class="dropdown-toggle disabled" data-toggle="dropdown"><B>HUMAN PRACTICE</B></H4></A><DIV class="dropdown-menu"><DIV class="subcategories_container"><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Human_Practices#research">Research</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Human_Practices#outreach">Outreach</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Human_Practices#impact">Impact</A></H5></DIV></DIV><DIV style="height:140px;"><H4>We don't just grow cool bacteria. We make a <B>difference</B>. Find out how we tackled <B>social aspects</B> of this project.</H4></DIV></DIV></LI><LI class="dropdown"><A href="https://2016.igem.org/Team:TAS_Taipei/Safety"><H4 class="dropdown-toggle disabled" data-toggle="dropdown"><B>SAFETY</B></H4></A><DIV class="dropdown-menu"><DIV style="height:100px;"><DIV class="subcategories_container"><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Safety#overview">Overview</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Safety#biosafety">Biosafety</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Safety#riskreduction">Risk Reduction Methods</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Safety#furtherquestion">Further Questions</A></H5></DIV></DIV><H4><B>Safety first.</B> Especially in a lab. Here's how we maintained and investigated the integrity and security of our work environment.</H4></DIV></DIV></LI><LI class="dropdown"><A href="https://2016.igem.org/Team:TAS_Taipei/Team"><H4 class="dropdown-toggle disabled" data-toggle="dropdown"><B>TEAM</B></H4></A><DIV class="dropdown-menu"><DIV class="subcategories_container"><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Team#members">Members</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Team#about">About</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Attributions">Attributions</A></H5></DIV><DIV><H5><A href="https://2016.igem.org/Team:TAS_Taipei/Wiki_Standard_Pages">Wiki Standard Pages</A></H5></DIV></DIV><DIV style="height:140px;"><H4>Every iGEM project is the accumulation of an entire year's hard work by a group of cheerful students. <B>Meet the team!</B></H4></DIV></DIV></LI></UL></NAV></DIV><DIV class="row center-block" style="padding:10px;width:90%;background-color:#07BEB8;box-shadow:0px 0px 5px black"><DIV class="row" style="text-align:center;"><DIV class="col-sm-8" style="text-align:center;"><A href="https://2016.igem.org/Team:TAS_Taipei" style="text-decoration: none;"><H2 style="font-family:'Lato';letter-spacing:10px;color: white; font-size: 60px;  margin-top: 0;  margin-bottom: 0;"><B>
						C◎UNTERACTS</B></H2></A></DIV></DIV></DIV><DIV class="row card" id="bodycontainer" class="row"><DIV class="col-sm-2" style="padding-left:8px;"><DIV id="category_navbar"><UL class="nav nav-list" data-spy="affix" data-offset-top="160" style="-webkit-transform: translateZ(0);width:160px;margin-left:0"><LI><A href="#survey">Survey</A></LI><LI><A href="#plan">Marketing Plan</A></LI><LI><A href="#synopsis">Synopsis</A></LI><LI><A href="#approach">Approach</A></LI></UL></DIV></DIV><DIV class="col-sm-10" style="padding-right:5%"><H1>Entrepreneurship</H1><DIV class="row"><DIV class="col-sm-12"><DIV class="row"><DIV class="col-sm-12"><H2 id="survey">Survey</H2><P>
                                        Based on our survey given to our school community and citizens of Taipei, we discovered that cost of cataract surgery, whether performed in humans or in pets, was a source of concern.  Many people said that if there was a safe, affordable option to surgery, that they would prefer that option.  With this information in mind, we ran a cost analysis to ensure that our solution would be affordable.
                                    </P></DIV></DIV><DIV class="row"><DIV class="col-sm-12"><H2 id="plan">Counteracts Marketing Plan</H2><P>
                                        With the help of our business and economics teacher, we developed a comprehensive marketing plan for our cataracts prevention and treatment products, in order to create a more profound impact in terms of public awareness of Cataracts.  Within this plan we performed a situational analysis based on market research, customer analysis, environmental/industrial considerations, and regulatory constraints (such as quality control and SWOT analysis). Furthermore, we statistically analyzed our products’ viability in the market by developing pricing and promotional strategies. Upon completion, we initiated discussions with several biotechnology investors and published our plan on business starter websites to garner interest. 
                                    </P></DIV></DIV><DIV class="row"><DIV class="col-sm-12"><H3>Marketing Plan Synopsis</H3><P>
                                        There exists a significant market opportunity for cataracts treatment worldwide. Over 3 million cataract surgeries are performed in the United States every year, and cataracts have attributes to 51% of world blindness. Although cataracts surgery is the dominant procedure in this market, we have developed technology which provides distinctive advantages, and created a marketing plan which serves as a guide for establishing a successful business. 
                                    </P></DIV></DIV><DIV class="row"><DIV class="col-sm-6"><H3>Marketing Plan Approach</H3><P>
                                        The total material cost of a 3 month supply is $7.88. 1 bottle contains 200 drops and can be used for both eyes for 3 months. 1 bottle contains 4.2 mg of proteins encapsulated in nanoparticles. Accounting for the protein encapsulation efficiency (72%) of our nanoparticles, we determined that we need to grow 160 mL of liquid culture in order to produce each bottle. Below is the material costs for making 1 bottle of our Counteracts eye drop.  
                                    </P><BUTTON type="button" class="btn btn-primary btn-lg"><A href="https://static.igem.org/mediawiki/2016/d/d5/T--TAS_Taipei--marketingplan.pdf">Click to download our market plan!</A></BUTTON></DIV></DIV><DIV class="row"><DIV class="col-sm-12"><TABLE class="table table-hover fixed" style="font:16px"><THEAD><TR><TH>Material</TH><TH>Unit</TH><TH>Price (NTD)</TH><TH>Amount Needed</TH><TH>Cost (NTD)</TH><TH>Cost (USD)</TH></TR></THEAD><TBODY align="right"><TR><TD>LB (LBL407)</TD><TD>1000 g</TD><TD>2700</TD><TD>4 g</TD><TD>15.56</TD><TD>0.50</TD></TR><TR><TD>Ampicillin Sigma Aldrich</TD><TD>5 g</TD><TD>3300</TD><TD>0.00016 g</TD><TD>1.52</TD><TD>0.05</TD></TR><TR><TD>Histag Column</TD><TD>1 column purifies 2000 mg protein</TD><TD>1581</TD><TD>5.761 mg</TD><TD>62.66</TD><TD>1.99</TD></TR><TR><TD>Xtractor buffer</TD><TD>500 mL</TD><TD>8280</TD><TD>6.4 mL</TD><TD>105.98</TD><TD>3.37</TD></TR><TR><TD>Wash buffer</TD><TD>500 mL</TD><TD>5041</TD><TD>2 mL</TD><TD>20.17</TD><TD>0.64</TD></TR><TR><TD>Elution buffer</TD><TD>250 mL</TD><TD>4931</TD><TD>2 mL</TD><TD>39.45</TD><TD>1.26</TD></TR><TR><TD>Sodium Tripolyphosphate</TD><TD>500 g</TD><TD>350</TD><TD>20 mg</TD><TD>0.01</TD><TD>0.00</TD></TR><TR><TD>Chitosan</TD><TD>250 g</TD><TD>6420</TD><TD>60 mg</TD><TD>1.54</TD><TD>0.05</TD></TR><TR><TD>Acetic Acid</TD><TD>500 mL</TD><TD>300</TD><TD>200 uL</TD><TD>0.12</TD><TD>0.00</TD></TR><TR><TD>Sodium Hydroxide</TD><TD>500 g</TD><TD>600</TD><TD>0.4 g</TD><TD>0.48</TD><TD>0.02</TD></TR></TBODY><TFOOT><TR><TD><B>$247.48</B></TD><TD><B>$7.88</B></TD></TR></TFOOT></TABLE></DIV></DIV><DIV class="row"><DIV class="col-sm-12"><FIGURE class="col-sm-4"><FIGCAPTION>Alexander Kaufman, former intern at RA Capital</FIGCAPTION></FIGURE><DIV class="col-sm-8"><P>
                                                Additionally,<B> Mr. Alexander Kaufman,</B> a former intern at RA Capital (a biotechnology investment firm), provided constructive feedback on our business plan. He suggested that we focus on long term cost projections, for it would put us in a better position to engage with venture capitalists. He also thought that our competitor analysis and initial market sizing was impressive. Furthermore, this plan was shown to Dr. Tai-Yuan Wang and he suggested that with an FDA approval and clinical trials, he would be interested in our products. Thus,we can conclude our products have the potential to compete in market.
                                            </P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV><DIV id="slideout"><DIV id="slidecontent"><H3>Prevention</H3><H5>GSR Eyedrop</H5><H3>Treatment</H3><H5>25HC Eyedrop</H5><H4><B> LOCS: <SPAN id="LOCS">0  </SPAN></B>  <BUTTON type="button" class="btn btn-danger btn-md"><A href="https://2016.igem.org/Team:TAS_Taipei/Wiki_Standard_Pages#Animation">?</A></BUTTON></H4><H2 class="vertical-text" style="Lato"> Eyedrops 
    </H2></DIV></DIV><DIV id="slideoutco"><DIV id="slidecontentco"><DIV id="slidecontenttext" class="alert alert-danger"><P style="font-size:14px !important"><A href="#" class="close" data-dismiss="alert">×</A><STRONG>Zoom out to see animation.</STRONG>     <BUTTON type="button" class="btn btn-danger btn-sm"><A href="https://2016.igem.org/Team:TAS_Taipei/Wiki_Standard_Pages#Animation">?</A></BUTTON><SPAN style="font-size:14px">Your screen resolution is too low unless you zoom out </SPAN></P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>